Literature DB >> 19202156

Pressure-volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sites.

Peter Paul H M Delnoy1, Jan Paul Ottervanger, Henk Oude Luttikhuis, Dick H S Vos, Arif Elvan, Anand R Ramdat Misier, Willem P Beukema, Paul Steendijk, Norbert M van Hemel.   

Abstract

AIMS: To evaluate the clinical utility of pressure-volume loop analyses during pacemaker/implantable cardioverter defibrillator (ICD) implantations to assess the optimal right ventricular (RV) and/or left ventricular (LV) lead position. METHODS AND
RESULTS: 29 patients with heart failure and chronic RV apical pacing were studied. Stroke work (SW), LV ejection fraction (LVEF), cardiac output (CO), and LV dP/dt(max) were assessed using a conductance catheter in the LV during RV apical, RV outflow tract, single-site LV, and biventricular pacing at different left-sided pacing locations. Left ventricular ejection fraction was 34.3 +/- 9.8%. Compared with baseline, RV outflow tract pacing showed a small increase of 4.0 +/- 6.4% in LV dP/dt(max) and no improvement in SW, LVEF, or CO. In the optimal biventricular configuration, SW increased 39 +/- 41%, LVEF increased 22 +/- 13%, CO increased 16 +/- 16%, and LV dP/dt(max) increased 10 +/- 11% (all P < 0.05). In 45% of the patients, the optimal LV lead position was found at a different location as the 'first choice' postero-lateral or lateral target vein.
CONCLUSION: Pressure-volume loop analysis during pacemaker/ICD implantations facilitates to determine the optimal LV pacing site. Patients with chronic RV pacing showed a significant acute improvement in LV function when LV pacing or biventricular pacing is applied.

Entities:  

Mesh:

Year:  2009        PMID: 19202156     DOI: 10.1093/eurheartj/ehp011

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

1.  AV interval optimization using pressure volume loops in dual chamber pacemaker patients with maintained systolic left ventricular function.

Authors:  Frank Eberhardt; Thorsten Hanke; Joern Fitschen; Matthias Heringlake; Frank Bode; Heribert Schunkert; Uwe K H Wiegand
Journal:  Clin Res Cardiol       Date:  2012-03-09       Impact factor: 5.460

2.  Increasing knowledge and changing views in cardiac resynchronization therapy.

Authors:  Laszlo Buga; John G F Cleland
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 3.  Pressure Volume System for Management of Heart Failure and Valvular Heart Disease.

Authors:  Frederick G P Welt; James C Fang
Journal:  Curr Cardiol Rep       Date:  2019-11-25       Impact factor: 2.931

Review 4.  How to improve outcomes with cardiac resynchronisation therapy: importance of lead positioning.

Authors:  Peter J Cowburn; Christophe Leclercq
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

5.  Clinical validation of a real-time data processing system for cardiac output and arterial pressure measurement during intraoperative biventricular pacing optimization.

Authors:  Christopher K Johnson; Santos E Cabreriza; Rana L Sahar; Alexander Rusanov; Daniel Y Wang; Bin Cheng; Mira S Gendy; T Alexander Quinn; Henry Michael Spotnitz
Journal:  ASAIO J       Date:  2012 May-Jun       Impact factor: 2.872

6.  Impact of acute changes of left ventricular contractility on the transvalvular impedance: validation study by pressure-volume loop analysis in healthy pigs.

Authors:  Vincenzo Lionetti; Simone Lorenzo Romano; Giacomo Bianchi; Fabio Bernini; Anar Dushpanova; Giuseppe Mascia; Martina Nesti; Franco Di Gregorio; Alberto Barbetta; Luigi Padeletti
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.